IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q1 FY27 results · Apr–Jun 2026
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹756.26 crore (up 37.1% from Q1 FY26) and net profit of ₹64.40 crore (up 89.8% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 756.26 | 551.69 | +37.1% | 619.45 | +22.1% |
| Other income | 8.18 | 7.37 | +11.0% | 1.84 | +344.6% |
| Total income | 764.44 | 559.06 | +36.7% | 621.29 | +23.0% |
| Profit before tax | 86.69 | 45.51 | +90.5% | 70.81 | +22.4% |
| Net profit for the period | 64.40 | 33.93 | +89.8% | 53.16 | +21.1% |
| EPS, basic (₹) | 2.20 | 1.16 | +89.7% | 1.81 | +21.5% |
| Net margin (%) | 8.5 | 6.2 | 8.6 |
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 756.26 | 551.69 | +37.1% | 619.45 | +22.1% |
| Other income | 8.18 | 7.37 | +11.0% | 1.74 | +370.1% |
| Total income | 764.44 | 559.06 | +36.7% | 621.19 | +23.1% |
| Profit before tax | 86.77 | 45.54 | +90.5% | 70.83 | +22.5% |
| Net profit for the period | 64.48 | 33.96 | +89.9% | 53.18 | +21.2% |
| EPS, basic (₹) | 2.20 | 1.16 | +89.7% | 1.81 | +21.5% |
| Net margin (%) | 8.5 | 6.2 | 8.6 |
Consolidated
- Filed with BSE
- 10 Aug 2026, 14:56 IST
- Board meeting
- 10 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2026, 14:56 IST
- Board meeting
- 10 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE